Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
PAs are required by pharmacy benefit managers for drugs that are high cost ($1000 or more per month), have the potential for abuse, require monitoring to reduce side effects or have shown low efficacy
A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes
Ludwig, C
However, they also pose risks, such as pancreatitis and kidney issues, highlighting the need for careful monitoring by healthcare providers
US$ 20.64
US$ 27.48
US$ 24.72
